Aquestive Therapeutics Inc
AQST
Get informed when a big investor buys or sells
+ FollowMarket Cap$502.05M
Close$
$-1.76
144.1% downside
Current Fair Value
144.1% downsideOvervalued by 144.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $502.05 Million |
|---|---|
| Enterprise Value | $463.65 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.76 |
| Beta | 1.49 |
| Outstanding Shares | 124,994,165 |
Return
| Return on Equity | 138.24% |
|---|---|
| Return on Assets | -59.22% |
| Return on Invested Capital | -57.65% |
Valuation & Multiples
| P/E Ratio | -6.15 |
|---|---|
| PEG | -8.95 |
| Price to Sales | - |
| Price to Book Ratio | -4.0 |
| Enterprise Value to Revenue | 8.57 |
| Enterprise Value to EBIT | -6.96 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | -1.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$11.42 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$11.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 28.55% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.70%▼ 57.16% |
|---|---|
| Total Invested | $4.03M▼ 98.66% |
| Investors Holding | 21▼ 174.00% |
ESG Score
No data